tofacitinib - Generic mfg.
Jyseleca (filgotinib) - Gilead
Rinvoq (upadacitinib) - AbbVie
Olumiant (baricitinib) - Eli Lilly
https://distribution-congress.eular.org/from.storage?image=15rRXWmdOAJ77zPlkD-rQj7333bWFdR8a3oS-x-HYzzuD_JPBa4if6uFQbXXk7l60
 
Carmen Lasa Teja1; Juan Jose Fernández-Cabero1; Ana Serrano-Combarro2; María Pilar Ortiz-Lavín2; Laura Muñoz Llopis2; Virginia Portilla González2; Carmen Bejerano2; Iñigo González Mazón2; Lara Sanchez-Bilbao2; Carolina Aguirre Portilla2; Javier Loricera2; José Luis Martín-Varillas3; Carmen Álvarez-Reguera2; Alba Herrero- Morant2; Montserrat Santos-Gómez4; Marcos López Hoyos1; Alfonso Corrales-Martínez2; Ricardo Blanco2
 
May 23, 2026
 
Prev Next